Home/Filings/4/0001014108-15-000228
4//SEC Filing

XZERES Corp. 4

Accession 0001014108-15-000228

CIK 0001084597operating

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 11:37 AM ET

Size

13.0 KB

Accession

0001014108-15-000228

Insider Transaction Report

Form 4
Period: 2015-06-09
DEBRUCE PAUL
10% Owner
Transactions
  • Purchase

    Series B Participating Preferred, par value $.001 per share

    2015-06-09$2000.00/sh+1,190$2,380,0001,190 total
Holdings
  • Warrants (right to buy)

    Exercise: $0.23From: 2013-07-31Exp: 2017-07-31Common Stock (976,658 underlying)
    976,658
  • Warrants (right to buy)

    Exercise: $0.30From: 2014-04-23Exp: 2018-04-23Common Stock (1,144,984 underlying)
    1,144,984
  • Warrants (right to buy)

    Exercise: $0.25From: 2013-10-01Exp: 2017-10-01Common Stock (687,047 underlying)
    687,047
  • Warrants (right to buy)

    Exercise: $0.31From: 2013-12-16Exp: 2016-12-16Common Stock (2,794,256 underlying)
    2,794,256
  • Common Stock, par value $.001 per share

    15,219,672
Footnotes (5)
  • [F1]The number of shares to which these warrants relate, as well as their respective exercise prices, are subject to antidilution adjustment provisions.
  • [F2]This warrant is exercisable for such number of shares as equals 1.03459% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $228,951, and previously was reported as relating to 829,246 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 976,658 shares of Common Stock upon payment of an aggregate exercise price of $228,951 ($0.2344 per share), subject to further adjustment under the warrant's antidilution provisions.
  • [F3]This warrant is exercisable for such number of shares as equals 0.7278% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $174,417, and previously was reported as relating to 583,347 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 687,047 shares of Common Stock upon payment of an aggregate exercise price of $174,417 ($0.2539 per share), subject to further adjustment under the warrant's antidilution provisions.
  • [F4]This warrant is exercisable for such number of shares as equals 2.96% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $855,555, and previously was reported as relating to 2,372,503 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 2,794,256 shares of Common Stock upon payment of an aggregate exercise price of $855,555 ($0.3062 per share), subject to further adjustment under the warrant's antidilution provisions.
  • [F5]This warrant is exercisable for such number of shares as equals 1.2129% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $339,206, and previously was reported as relating to 972,165 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 1,144,984 shares of Common Stock upon payment of an aggregate exercise price of $339,206 ($0.2963 per share), subject to further adjustment under the warrant's antidilution provisions.

Issuer

XZERES Corp.

CIK 0001084597

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001084597

Filing Metadata

Form type
4
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 11:37 AM ET
Size
13.0 KB